Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|April 16, 2014
Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B proteinVincent W-F Tai, Dulce Garrido, Daniel J Price, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Novel pyrazolopyrimidine derivatives as GSK-3 inhibitorsAndrew J Peat, Joyce A Boucheron, Scott H Dickerson, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2008
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residuesSteven M Sparks, Pierette Banker, David M Bickett, et al.British Journal of Pharmacology|May 17, 2006
Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small moleculesCelia P Briscoe, Andrew J Peat, Stephen C McKeown, et al.Antimicrobial Agents and Chemotherapy|August 12, 2015
Preclinical Characterization and In Vivo Efficacy of GSK8853, a Small-Molecule Inhibitor of the Hepatitis C Virus NS4B ProteinJeffrey J Pouliot, Michael Thomson, Mi Xie, et al.Journal of Medicinal Chemistry|February 15, 2019
Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV InhibitorPek Y Chong, J Brad Shotwell, John Miller, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2008
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroupsSteven M Sparks, Pierette Banker, David M Bickett, et al.Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacyStephen A Thomson, Pierette Banker, D Mark Bickett, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Imidazo[1,2-a]pyridines That Directly Interact with Hepatitis C NS4B: Initial Preclinical CharacterizationJ Brad Shotwell, Subramanian Baskaran, Pek Chong, et al.Journal of Medicinal Chemistry|November 28, 2006
Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1Francis X Tavares, Kamal A Al-Barazanji, Eric C Bigham, et al.Pageof 3